NATCOPHARMPharmaceuticals
Natco Pharma Ltd — Balance Sheet
₹974.20
+0.51%
Natco Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 17.91 Cr | 17.91 Cr | 18.25 Cr | 18.25 Cr | — |
| Share Issued | 17.91 Cr | 17.91 Cr | 18.26 Cr | 18.25 Cr | — |
| Net Debt | 153.10 Cr | 307.70 Cr | 42.50 Cr | 309.40 Cr | — |
| Total Debt | 279.40 Cr | 386.10 Cr | 176.10 Cr | 432.00 Cr | — |
| Tangible Book Value | 7.34K Cr | 5.66K Cr | 4.69K Cr | 4.13K Cr | — |
| Invested Capital | 7.88K Cr | 6.23K Cr | 5.05K Cr | 4.68K Cr | — |
| Working Capital | 4.33K Cr | 3.05K Cr | 2.32K Cr | 1.78K Cr | — |
| Net Tangible Assets | 7.34K Cr | 5.66K Cr | 4.69K Cr | 4.13K Cr | — |
| Capital Lease Obligations | 6.30 Cr | 8.00 Cr | 1.70 Cr | 11.50 Cr | — |
| Common Stock Equity | 7.61K Cr | 5.85K Cr | 4.87K Cr | 4.26K Cr | — |
| Total Capitalization | 7.61K Cr | 5.85K Cr | 4.87K Cr | 4.26K Cr | — |
| Total Equity Gross Minority Interest | 7.61K Cr | 5.85K Cr | 4.87K Cr | 4.26K Cr | — |
| Minority Interest | 5.30 Cr | 0.00 | 0.00 | 0.00 | — |
| Stockholders Equity | 7.61K Cr | 5.85K Cr | 4.87K Cr | 4.26K Cr | — |
| Other Equity Interest | 7.57K Cr | 5.82K Cr | 4.84K Cr | 3.40 Cr | — |
| Capital Stock | 35.80 Cr | 35.80 Cr | 36.50 Cr | 36.50 Cr | — |
| Common Stock | 35.80 Cr | 35.80 Cr | 36.50 Cr | 36.50 Cr | — |
| Total Liabilities Net Minority Interest | 1.02K Cr | 1.05K Cr | 783.60 Cr | 845.50 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 75.00 Cr | 80.40 Cr | 100.50 Cr | 135.10 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.20 Cr | 0.20 Cr | 12.40 Cr | 30.10 Cr | — |
| Long Term Debt And Capital Lease Obligation | 4.60 Cr | 5.30 Cr | 1.10 Cr | 8.00 Cr | — |
| Long Term Capital Lease Obligation | 4.60 Cr | 5.30 Cr | 1.10 Cr | 8.00 Cr | — |
| Long Term Provisions | 65.60 Cr | 70.90 Cr | 85.30 Cr | 95.70 Cr | — |
| Current Liabilities | 943.50 Cr | 972.80 Cr | 683.10 Cr | 710.40 Cr | — |
| Other Current Liabilities | 122.30 Cr | 48.80 Cr | 54.60 Cr | 36.90 Cr | — |
| Current Debt And Capital Lease Obligation | 274.80 Cr | 380.80 Cr | 175.00 Cr | 424.00 Cr | — |
| Current Capital Lease Obligation | 1.70 Cr | 2.70 Cr | 0.60 Cr | 3.50 Cr | — |
| Current Debt | 273.10 Cr | 378.10 Cr | 174.40 Cr | 420.50 Cr | — |
| Current Provisions | 77.90 Cr | 102.90 Cr | 16.90 Cr | 17.00 Cr | — |
| Payables | 353.90 Cr | 303.70 Cr | 311.30 Cr | 197.70 Cr | — |
| Total Tax Payable | 79.00 Cr | 32.30 Cr | 10.10 Cr | 0.90 Cr | — |
| Accounts Payable | 274.90 Cr | 235.50 Cr | 263.80 Cr | 161.80 Cr | — |
| Total Assets | 8.63K Cr | 6.91K Cr | 5.66K Cr | 5.11K Cr | — |
| Total Non Current Assets | 3.36K Cr | 2.88K Cr | 2.66K Cr | 2.62K Cr | — |
| Other Non Current Assets | 49.00 Cr | 69.40 Cr | 27.10 Cr | 46.90 Cr | — |
| Non Current Deferred Taxes Assets | 50.10 Cr | 19.40 Cr | 0.00 | — | — |
| Investmentin Financial Assets | 335.10 Cr | 95.90 Cr | 87.30 Cr | 104.40 Cr | — |
| Available For Sale Securities | 335.10 Cr | 37.10 Cr | 35.90 Cr | 46.10 Cr | — |
| Goodwill And Other Intangible Assets | 266.10 Cr | 193.10 Cr | 187.80 Cr | 132.90 Cr | — |
| Other Intangible Assets | 208.70 Cr | 137.10 Cr | 132.60 Cr | 82.20 Cr | — |
| Goodwill | 57.40 Cr | 56.00 Cr | 55.20 Cr | 50.70 Cr | — |
| Net PPE | 2.66K Cr | 2.44K Cr | 2.30K Cr | 2.31K Cr | — |
| Gross PPE | 2.66K Cr | 3.50K Cr | 3.22K Cr | 3.10K Cr | — |
| Construction In Progress | 225.40 Cr | 137.30 Cr | 64.30 Cr | 129.50 Cr | — |
| Other Properties | 2.43K Cr | 50.30 Cr | 45.00 Cr | 55.60 Cr | — |
| Current Assets | 5.27K Cr | 4.02K Cr | 3.00K Cr | 2.49K Cr | — |
| Other Current Assets | 330.90 Cr | 275.90 Cr | 229.00 Cr | 304.30 Cr | — |
| Inventory | 765.80 Cr | 700.50 Cr | 742.90 Cr | 762.00 Cr | — |
| Other Receivables | 9.40 Cr | 79.60 Cr | 45.30 Cr | 64.90 Cr | — |
| Accounts Receivable | 1.25K Cr | 1.19K Cr | 856.10 Cr | 620.60 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 2.92K Cr | 1.78K Cr | 1.12K Cr | 759.90 Cr | — |
| Other Short Term Investments | 2.80K Cr | 1.71K Cr | 992.90 Cr | 648.80 Cr | — |
| Cash And Cash Equivalents | 120.00 Cr | 70.40 Cr | 131.90 Cr | 111.10 Cr | — |
| Retained Earnings | — | 4.47K Cr | 3.29K Cr | 2.67K Cr | 2.57K Cr |
| Additional Paid In Capital | — | 1.20K Cr | 1.41K Cr | 1.41K Cr | 1.39K Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 70.90 Cr | 85.30 Cr | 95.70 Cr | 99.60 Cr |
| Non Current Deferred Revenue | — | 4.00 Cr | 1.70 Cr | 1.30 Cr | 1.10 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 102.90 Cr | 16.90 Cr | 17.00 Cr | 12.80 Cr |
| Other Payable | — | 32.80 Cr | 33.70 Cr | 31.30 Cr | 40.10 Cr |
| Dividends Payable | — | 3.10 Cr | 3.70 Cr | 3.70 Cr | 3.70 Cr |
| Non Current Prepaid Assets | — | 111.90 Cr | 43.90 Cr | 61.70 Cr | 42.90 Cr |
| Held To Maturity Securities | — | 58.80 Cr | 51.40 Cr | 58.30 Cr | 110.40 Cr |
| Accumulated Depreciation | — | -1.06K Cr | -912.30 Cr | -794.00 Cr | -662.70 Cr |
| Machinery Furniture Equipment | — | 1.83K Cr | 1.76K Cr | 1.68K Cr | 1.50K Cr |
| Buildings And Improvements | — | 1.11K Cr | 1.06K Cr | 973.40 Cr | 896.60 Cr |
| Land And Improvements | — | 369.20 Cr | 285.50 Cr | 264.10 Cr | 247.60 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 3.10 Cr | 4.70 Cr | 3.70 Cr | 3.70 Cr |
| Prepaid Assets | — | 273.30 Cr | 226.50 Cr | 274.60 Cr | 227.10 Cr |
| Other Inventories | — | 43.00 Cr | 30.60 Cr | 32.80 Cr | 31.10 Cr |
| Finished Goods | — | 273.10 Cr | 286.60 Cr | 212.90 Cr | 163.70 Cr |
| Work In Process | — | 102.30 Cr | 129.30 Cr | 175.00 Cr | 183.40 Cr |
| Raw Materials | — | 282.10 Cr | 296.40 Cr | 341.30 Cr | 420.00 Cr |
| Allowance For Doubtful Accounts Receivable | — | -19.70 Cr | -15.00 Cr | -42.20 Cr | -15.10 Cr |
| Gross Accounts Receivable | — | 1.21K Cr | 871.10 Cr | 662.80 Cr | 428.00 Cr |
| Cash Equivalents | — | 6.30 Cr | 0.00 | — | — |
| Cash Financial | — | 64.10 Cr | 131.90 Cr | 111.10 Cr | 25.80 Cr |
| Treasury Shares Number | — | — | 87050.00 | — | — |
| Other Non Current Liabilities | — | — | -4.26K Cr | — | — |
| Hedging Assets Current | — | — | 0.00 | 1.00 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Natco Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.